The relative contribution of beneficial over deleterious TNF functions to one human demyelinating disease, multiple sclerosis (MS), are clearly illustrated by clinical data, which show that non-selective TNF inhibitors exacerbate disease in MS patients [3] and induce de novo demyelination in patients treated for other diseases [4, 5]. Here, TNF is linked to demyelinating disease.